𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Failure of combination therapy with recombinant granulocyte colony-stimulating factor and erythropoietin in myelodyspplastic syndromes

✍ Scribed by M. Imamura; S. Kobayashi; K. Sakurada; T. Miyazaki; M. Kobayashi; K. Yoshida; C. Mikuni; Y. Ishikawa; S. Matsumoto; S. Sakamaki; Y. Niitsu; Y. Hinoda; A. Yachi; T. Kudoh; S. Chiba; M. Kasai; T. Oka; A. Okuno; I. Maekawa


Publisher
Springer
Year
1994
Tongue
English
Weight
329 KB
Volume
68
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Combination Therapy With Recombinant Hum
✍ Dr. Masahiro Imamura; Masanobu Kobayashi; Sumiko Kobayashi; Kohki Yoshida; Chika πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 430 KB πŸ‘ 1 views

## Abstract Recombinant human granulocyte colony‐stimulating factor (rhG‐CSF) and erythropoietin (rhEPO) were used to treat patients with aplastic anemia (AA). In terms of effects on erythrocyte recovery, the combined use of rhG‐CSF and rhEPO showed a favorable response in 6 of 14 (42.9%) patients

Treatment of severe aplastic anemia with
✍ Zonghong Shao; Yulin Chu; Yizhi Zhang; Guibin Chen; Yizhou Zheng πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 44 KB πŸ‘ 2 views

To evaluate the therapeutic potential of hematopoietic growth factors (HGFs) during immunosuppressive treatment (IST) of severe aplastic anemia (SAA), 38 patients with newly diagnosed SAA received IST alone (group I), or IST plus recombinant human erythropoietin and granulocyte-macrophage colony-sti